Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05370833
Other study ID # MP-31-2022-4640
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 15, 2022
Est. completion date May 30, 2024

Study information

Verified date July 2023
Source Université de Sherbrooke
Contact Guillaume Leonard, PhD
Phone 819-780-2220
Email guillaume.leonard2@usherbrooke.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic pain is one of the main factors influencing workers' retention at work. Considering that the prevalence of suffering from chronic pain increases with age, older workers are most likely to be absent from work because of their pain. Transcranial direct current stimulation (tDCS) is a treatment option to reduce chronic pain. This study aims to document the effect of tDCS on pain and work retention in older workers and to compare the traditional tDCS protocol (5 sessions) with an enhanced protocol (11 sessions).


Description:

Chronic pain affects many spheres of the lives of affected individuals and those around them. In Canada, the prevalence of chronic pain is estimated at 15% of adults aged 18 and over. Among seniors, the prevalence of this health problem can reach up to 50% and affect one in two seniors. Chronic pain is one of the leading causes of work disability. In this context, pain reduction remains one of the most effective methods to enable the worker to stay at work. Considering the aging Quebec population, labor needs and the average retirement age which is increasingly postponed, it becomes crucial to take an interest in aging workers and their continued employment. Transcranial direct current stimulation (tDCS) is a non-invasive neurostimulation method that has shown promise in reducing chronic pain. Recently, several research teams have shown that tDCS has beneficial effects on pain, physical function and social participation in seniors. Despite all these recent advances, very few studies have focused on optimizing tDCS treatment modalities and no studies have focused on the impact of tDCS on return to work or retention. The vast majority of studies using tDCS to reduce pain give one tDCS session per day for 5 consecutive days. This study aims to document the effect of tDCS on pain and work retention in older workers and to compare the traditional tDCS protocol (5 sessions) with an enhanced protocol (11 sessions).


Recruitment information / eligibility

Status Recruiting
Enrollment 24
Est. completion date May 30, 2024
Est. primary completion date April 30, 2024
Accepts healthy volunteers No
Gender All
Age group 56 Years and older
Eligibility Inclusion Criteria: - To be more than 55 years old - To have chronic pain - To have employment relationship - To have pain that interferes with work tasks Exclusion Criteria: - tDCS contraindications (epilepsy, metallic implant in the head, pacemaker, cochlear implant)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
transcranial direct current stimulation
Anodal, 2mA, tDCS session applied on M1 for 20 minutes.

Locations

Country Name City State
Canada Clinique régionale de la gestion de la douleur - CISSSAT Rouyn-Noranda Quebec
Canada Centre de Recherche sur le Vieillissement Sherbrooke Quebec

Sponsors (2)

Lead Sponsor Collaborator
Université de Sherbrooke CISSS Abitibi-Témiscamingue

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain intensity 0-10 Numerical rating scale Before tDCS
Primary Pain intensity 0-10 Numerical rating scale 1 week
Primary Pain intensity 0-10 Numerical rating scale 4 weeks
Primary Pain intensity 0-10 Numerical rating scale 4 weeks after the last tDCS session
Primary Disability Pain Disability Index Before tDCS
Primary Disability Pain Disability Index 1 week
Primary Disability Pain Disability Index 4 weeks
Primary Disability Pain Disability Index 4 weeks after the last tDCS session
Primary Work role functioning Work Role Functioning Questionnaire Before tDCS
Primary Work role functioning Work Role Functioning Questionnaire 1 week
Primary Work role functioning Work Role Functioning Questionnaire 4 weeks
Primary Work role functioning Work Role Functioning Questionnaire 4 weeks after the last tDCS session
Primary Physical Functioning Brief Pain Inventory Before tDCS
Primary Physical Functioning Brief Pain Inventory 1 week
Primary Physical Functioning Brief Pain Inventory 4 weeks
Primary Physical Functioning Brief Pain Inventory 4 weeks after the last tDCS session
Primary Anxiety Beck anxiety inventory Before tDCS
Primary Anxiety Beck anxiety inventory 1 week
Primary Anxiety Beck anxiety inventory 4 weeks
Primary Anxiety Beck anxiety inventory 4 weeks after the last tDCS session
Primary Depression Beck depression inventory Before tDCS
Primary Depression Beck depression inventory 1 week
Primary Depression Beck depression inventory 4 weeks
Primary Depression Beck depression inventory 4 weeks after the last tDCS session
Primary Impression of change Patient Global impression of change 1 week
Primary Impression of change Patient Global impression of change 4 weeks
Primary Impression of change Patient Global impression of change 4 weeks after the last tDCS session
Primary Central sensitization central sensitization inventory Before tDCS
Primary Central sensitization central sensitization inventory 1 week
Primary Central sensitization central sensitization inventory 4 weeks
Primary Central sensitization central sensitization inventory 4 weeks after the last tDCS session
Secondary Recruitment Feasibility of the study through study completion, about 2 years
Secondary Security Feasibility of the study through study completion, about 2 years
Secondary Intervention Feasibility of the study through study completion, about 2 years
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain